What Are the Challenges in Nanotechnology-based Drug Development?
Despite its potential, nanotechnology-based drug development faces several challenges:
Toxicity: The long-term toxicity of nanoparticles is not fully understood, and there is a need for comprehensive safety evaluations. Regulatory Hurdles: The regulatory framework for nanomedicines is still evolving, which can delay the approval and commercialization of new treatments. Manufacturing Complexity: The production of nanoparticles requires specialized equipment and processes, which can be costly and complex. Stability: Ensuring the stability of nanoparticles during storage and upon administration is crucial for their effectiveness.
